Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs7636844 | chr3:45927211 | C/T | 1.71E-5 | 493 | 32.98 | 27.42 | 8.77 | KM Plot |
| PRAD | rs76389436 | chr4:187812752 | A/G | 2.06E-6 | 483 | 31.13 | 28.57 | 26.8 | KM Plot |
| PRAD | rs76403911 | chr7:157942092 | T/G | 0 | 481 | 31.27 | 30.8 | 12.87 | KM Plot |
| PRAD | rs76411907 | chr12:10737959 | C/A | 6.01E-5 | 485 | 30.8 | 32.63 | 19.93 | KM Plot |
| PRAD | rs76423273 | chr5:154233214 | C/T | 0 | 493 | 30.08 | 36.05 | 4.87 | KM Plot |
| PRAD | rs76466448 | chr2:107455805 | A/G | 0.000133 | 491 | 30.73 | 31.07 | 32.63 | KM Plot |
| PRAD | rs7648520 | chr3:112501790 | T/C | 2.15E-7 | 494 | 30.78 | 33.72 | 17.77 | KM Plot |
| PRAD | rs76496098 | chr15:83229141 | T/C | 4.33E-8 | 479 | 30.8 | 32.08 | 29.08 | KM Plot |
| PRAD | rs76502131 | chr1:1157959 | C/T | 3.49E-9 | 490 | 31.27 | 30.73 | 13.73 | KM Plot |
| PRAD | rs76509445 | chr5:154312389 | T/C | 0 | 493 | 30.23 | 32.85 | 4.87 | KM Plot |
| PRAD | rs76514175 | chr6:43347125 | A/G | 5.6E-10 | 483 | 31.25 | 28.98 | 44.3 | KM Plot |
| PRAD | rs76514855 | chr4:187812479 | C/T | 2.19E-6 | 481 | 31.13 | 28.57 | 26.8 | KM Plot |
| PRAD | rs76520356 | chr11:129955573 | C/T | 1.96E-6 | 494 | 30.87 | 32.22 | 22.8 | KM Plot |
| PRAD | rs76525433 | chr2:47155382 | T/G | 6.41E-6 | 492 | 30.8 | 32.4 | 36.85 | KM Plot |
| PRAD | rs76550775 | chr20:61675116 | G/A | 7.16E-6 | 489 | 31.07 | 31.37 | 24.15 | KM Plot |